CME - Vortioxetine: Dr Swaleha Mujawar MD

#vortioxetine #antidepressant
0:00 Introduction
1:16 Common Screening Instruments for MDD
1:36 The definition of treatment success in depression has EVOLVED
2:43 Cognitive symptoms of depression have a negative impact on many aspects of the patient's life.
3:14 Cognitive symptoms are one of the most common residual symptoms in MDD
4:05 The Evolution of Antidepressants
5:01 To overcome therapeutic unmet needs & achieve key objectives in depression
5:32 Pharmacodynamics
7:06 Indication and Dosage
7:37 Pharmacokinetics
8:29 Use in Special Population
10:49 Remission Rate
14:35 Impact on Sleep
17:25 Effect on Body Weight
18:28 Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed
19:20 Safety, Tolerability & Dosing Frequency
22:43 Summary
24:58 Vortioxetine Achieves Key Therapeutic Objectives